Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 19Gastrointestinal 17Lymphoid 8Gynecologic 6Breast 5Genitourinary 3Other hematologic neoplasm 2Head & Neck 2Dermatologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Other 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Folic Acid × Other neoplasm × Clear all
NCT00703196 2015-10-08

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

University of Alabama at Birmingham

Phase 2 Completed
368 enrolled
GynecologicOther neoplasm

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡